Reference:
1. Rooden CJV, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and Risk Factors of Early Venous Thrombosis Associated with Permanent Pacemaker Leads. J Cardiovasc Electrophysiol. 2004;15(11):1258–62.
2. Abu‐El‐Haija Basil, Bhave Prashant D., Campbell Dwayne N., Mazur Alexander, Hodgson‐Zingman Denice M., Cotarlan Vlad, et al. Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients. J Am Heart Assoc. 4(8):e001878.
3. Stoney WS, Addlestone RB, Alford WC, Burrus GR, Frist RA, Thomas CS. The Incidence of Venous Thrombosis Following Long-Term Transvenous Pacing. :5.
4. Zou F, Brar V, Worley SJ. Interventional device implantation, Part I: Basic techniques to avoid complications: A hands-on approach. J Cardiovasc Electrophysiol. 2020 Sep 18;
5. Spittell PC, Hayes DL. Venous Complications After Insertion of a Transvenous Pacemaker. Mayo Clin Proc. 1992 Mar 1;67(3):258–65.
6. Riley RF, Petersen SE, Ferguson JD, Bashir Y. Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol PACE. 2010 Apr;33(4):420–5.
7. Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. EP Eur. 2018 Jul 1;20(7):1217–1217.
8. Fu H-X, Huang X-M, Zhong L, Osborn MJ, Bjarnason H, Mulpuru S, et al. Outcome and Management of Pacemaker-Induced Superior Vena Cava Syndrome: PACEMAKER-INDUCED SUPERIOR VENA CAVA SYNDROME. Pacing Clin Electrophysiol. 2014 Nov;37(11):1470–6.
9. Goto Y, Abe T, Sekine S, Sakurada T. Long-Term Thrombosis after Transvenous Permanent Pacemaker Implantation. Pacing Clin Electrophysiol. 1998;21(6):1192–5.
10. Tarakji KG, Saliba W, Markabawi D, Rodriguez ER, Krauthammer Y, Brunner MP, et al. Unrecognized venous injuries after cardiac implantable electronic device transvenous lead extraction. Heart Rhythm. 2018 Mar;15(3):318–25.
11. Worley SJ, Gohn DC, Pulliam RW, Raifsnider MA, Ebersole BI, Tuzi J. Subclavian venoplasty by the implanting physicians in 373 patients over 11 years. Heart Rhythm. 2011 Apr 1;8(4):526–33.
12. Beathard GA. The Treatment of Vascular Access Graft Dysfunction: A Nephrologist’s View And Experience. Adv Ren Replace Ther. 1994 Jul 1;1(2):131–47.
13. Buriánková E, Köcher M, Bachleda P, Utíkal P, Kojecký Z, Černá M, et al. Endovascular treatment of central venous stenoses in patients with dialysis shunts. Biomed Pap. 2003 Dec 1;147(2):203–6.
14. Kitrou PM, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E, et al. Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial. J Vasc Interv Radiol. 2017 Jun;28(6):811–7.
15. Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med 2020 Aug 19 doi/10.1056/NEJMoa1914617
16. Massmann A, Fries P, Obst-Gleditsch K, Minko P, Shayesteh-Kheslat R, Buecker A. Paclitaxel-Coated Balloon Angioplasty for Symptomatic Central Vein Restenosis in Patients With Hemodialysis Fistulas. J Endovasc Ther. 2015 Feb 1;22(1):74–9.
17. Kennedy SA, Mafeld S, Baerlocher MO, Jaberi A, Rajan DK. Drug-Coated Balloon Angioplasty in Hemodialysis Circuits: A Systematic Review and Meta-Analysis. J Vasc Interv Radiol. 2019 Apr 1;30(4):483-494.e1.